Cargando…
Multidimensional biomarkers for multiple system atrophy: an update and future directions
Multiple system atrophy (MSA) is a fatal progressive neurodegenerative disease. Biomarkers are urgently required for MSA to improve the diagnostic and prognostic accuracy in clinic and facilitate the development and monitoring of disease-modifying therapies. In recent years, significant research eff...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375766/ https://www.ncbi.nlm.nih.gov/pubmed/37501056 http://dx.doi.org/10.1186/s40035-023-00370-0 |